Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2026-01-05 @ 3:52 AM
Study NCT ID:
NCT01956669
Status:
COMPLETED
Last Update Posted:
2020-08-12
First Post:
2013-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-08
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-05
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-01
First Submit QC Date:
None
Study First Post Date:
2013-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-05-04
Results First Submit QC Date:
None
Results First Post Date:
2020-08-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-27
Last Update Post Date:
2020-08-12
Last Update Post Date Type:
ACTUAL